Dr James Buchanan is a Senior Lecturer in Health Economics at Queen Mary University of London (QMUL). At QMUL, he leads work on the health economic aspects of precision diagnosis and treatment and translation research, across the Barts Biomedical Research Centre. His research focuses on applying economic methods to quantify the value of precision medicine for stakeholders in the health system. He has a particular interest in understanding the costs and benefits of genome sequencing in people with cancer and rare diseases, and in newborns. He has undertaken and published economic evaluations, outcomes studies, microcosting analyses, and discrete choice experiments in this space, working alongside national population sequencing initiatives such as the Genomics England 100,000 Genomes Project and the Generation Study.